Page 52 - Ciences News Today

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company

LOS ANGELES — It’s Earth’s original disrupter — a recurring climate pattern so powerful that it can drive global average temperature to record highs, and generate both cliff-crumbling storms and

HUNTSVILLE, Ala., May 18, 2023 /PRNewswire/ -- Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists, announced today that it has officially qualified as one of Akoya

NEW YORK, May 17, 2023) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that its Chief Medical

California’s $31.5-billion budget deficit is bad news for good bills. If proposed legislation carries a price tag, even if it’s speculative, it’s going to have a hard time getting past

MyJournals.org - Science - Examining public health practitioners` perceptions and use of behavioural sciences to design health promotion interventions (BMC Health Services Research)

More than 1 in 3 individuals with endometriosis and almost 1 in 5 individuals with uterine fibroids have considered quitting work or school due to symptoms Results from a self-selected survey

Kinlytic® urokinase to be developed for re-entry into U.S. marketMISSISSAUGA, Ontario, May 16, 2023 -- Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter,... | May 16, 2023

45.4% of subjects receiving VTAMA achieved the primary endpoint of vIGA-ADTM response of clear (0) or almost clear (1) with at least a 2-grade improvement from baseline at Week 8, versus 13.9% on

Regulatory News: Azelis (Brussels:AZE), a leading global innovation service provider in the specialty chemicals and food ingredients industry, announces that it has signed an agreement to acquire